IndraLab

Statements

BRCC3 inhibits Nasopharyngeal Carcinoma. 1 / 1

| 1

reach

"For example, in nasopharyngeal carcinoma, BRCC3 knockdown increased cell survival, attenuated DNA damage repair, and led to G2/M cell cycle arrest in radioresistant nasopharyngeal carcinoma cells [22]."

38449391

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

BRCC3 inhibits Nasopharyngeal Carcinoma. 1 / 1

INDRA sources:

Databases

Reading